Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

CBBC's Operation Ouch have been helping to raise awareness of participation in clinical trials for children.

Kadoorie logo

CRAFFT logo Science Trial Logo

 

CI of the CRAFFT and SCIENCE trials, Daniel Perry, tells us about the team's recent work with CBBC's Operation Ouch!

"Involving individuals in decisions about their treatment is somewhat of an art - requiring information to be delivered to them in a way that is engaging, appropriate and thorough. This is made more difficult when introducing uncertainty, and offering the opportunities to participate in a randomised trial. This is therefore especially difficult when then patient is a child, the disease is an injury, and the treatment is whether or not to have an operation.

The team for the children’s trauma studies CRAFFT and SCIENCE have enlisted some help in communicating the uncertainty - in the form of TV stars from CBBC's Operation Ouch, twins Dr Xand & Dr Chris van Tulleken. Their simple explanation of these trials makes is accessible to everyone - and is a pleasure to watch."

The OCTRU team think the video is excellent - watch on Twitter by clicking here

 

Visit the CRAFFT trial website.

Visit the SCIENCE trial website.

Similar stories

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Three NIHR HTA grants awarded to Professor Tim Theologis

Congratulations to Professor Tim Theologis, who has been awarded three NIHR HTA grants to extend research in orthopaedic disorders in children.

Going straight to surgery found to be better than undergoing rehabilitation first for longstanding anterior cruciate ligament injury

New research, funded by the National Institute for Health and Care Research (NIHR), shows initial surgery to be more successful and cost effective than undergoing treatment with rehabilitation first to treat longstanding anterior cruciate ligament injury.

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.